martes, 18 de agosto de 2020

Aspartate β-hydroxylase as a target for cancer therapy | Journal of Experimental & Clinical Cancer Research | Full Text

Aspartate β-hydroxylase as a target for cancer therapy | Journal of Experimental & Clinical Cancer Research | Full Text

As metastasis is a major cause of death in cancer patients, new anti-metastatic strategies are needed to improve cancer therapy outcomes. Numerous pathways have been shown to contribute to migration and invasi...
Authors:Madiha Kanwal, Michal Smahel, Mark Olsen, Jana Smahelova and Ruth Tachezy
Citation:Journal of Experimental & Clinical Cancer Research 2020 39:163
Content type:Review
 
Published on: 

No hay comentarios:

Publicar un comentario